MIAMS 2008

MICCAI workshop on "Medical Image Analysis on Multiple Sclerosis (validation and methodological issues)"

September 6th, 09:00-18:00, room 910, Kimmel Center, 60 Washington Square South, ·New York University ·NYC ·USA (Building 45 on map)

FINAL PROGRAM AVAILABLE __HERE__ (with presentations)

MIAMS'08 Proceedings AVAILABLE

MIAMS'08 Evaluation Survey Report from the conference attendees


Multiple Sclerosis is an inflammatory and demyelinating disease that exhibits regions with high demyelinating activity shown as focal lesions on MRI that usually affects young adults. Even in normal appearing brain tissues (NABT) there are alterations often not visible on conventional MRI sequences. While MRI has a low specificity for differentiating between possible pathological changes which could aid in discriminating between the different lesion types, it has a high sensitivity to detect focal and also widespread, diffuse pathology of the normal appearing white and grey matter. The objective of medical image analysis procedures is to define new neuroimaging biomarkers to track the evolution of the pathology from high dimensional data. This workshop will give an overview of new advances of medical image acquisition and analysis in Multiple Sclerosis.


The objective of this workshop is to bring together researchers in medical image analysis, biologists, radiologists and neurologists working in the field of neuroimaging biomarkers in MS. These methods are key for a better understanding of the different stages of the disease, for a better modelling of the natural history of the pathology, and for efficacy studies in clinical trials.

We solicit papers that use methods of medical image analysis methods in the following domains:

  • Focal and diffuse lesion segmentation in MS
  • Longitudinal data analysis in MS
  • New MRI sequences, molecular imaging, contrast agents in MS
  • Quantitative Imaging in MS (e.g. T2, T2*, MT, MRS, MRSI, Gado…)
  • Atrophy quantification in MS
  • DTI analysis in MS
  • Functional imaging in MS
  • New imaging modalities in MS (e.g., PET)
  • Myelin imaging
  • Spinal cord Imaging
  • Grey matter lesion imaging and detection
  • Tissue segmentation
  • Imaging and histological correlation
  • Animal models and imaging

Key Dates

  • Submission Deadline (Extension): May 19th
  • Notification for acceptation: June 30th
  • Final version of papers: August 10th


Christian BARILLOT Unit/Project VisAGeS - U746 INSERM/INRIA, IRISA, CNRS 6074, Univ. of Rennes1, Rennes, France

D. Louis COLLINS McConnell Brain Imaging Center, Montreal Neurological Institute, QC, CANADA

Keynote Speakers

  • Prof. Douglas ARNOLD from McGill University, Montreal will give a lecture on imaging biomarkers in Multiple Sclerosis.


  • The Preliminary Program is available __here__


Final Submission

Program Committee

  • Jean-Paul Armspach, University Louis Pasteur, Strasbourg, France
  • Isabelle Berry, INSERM, Toulouse, France
  • James Gee, U. of Pennsylvania, Philadelphia, PA
  • Hayit Greenspan, Tel-Aviv University, Israel
  • Charles Guttmann, Harvard Medical School, Boston, MA
  • Ron Kikinis, Brigham and Women’s Hospital, Boston, MA
  • Grégoire Malandain, INRIA Sophia-Antipolis, France
  • Sean-Patrick Morrissey, INSERM & Neurology Dept, Rennes, France
  • Ponada Narayana, U. Houston, TX
  • Sridar Narayanan, U. Mc Gill, Montreal, Canada
  • Elisabetta Pagani, San Raffaele Scientific Institute, Milan, Italy
  • Marcel Prastawa, University of Utah, Salt Lake City, UT
  • Sylvain Prima, INRIA, Rennes, France
  • Jean-Philippe Ranjeva, CNRS, Marseille, France
  • François Rousseau, LSIIT-CNRS, Strasbourg, France
  • Koen Van Leemput, MIT, Cambridge, MA
  • Simon K. Warfield, Harvard Medical School, Boston, MA


start.txt · Last modified: 2009/05/06 14:26 by auteurmiams